Clinical study to evaluate efficacy and safety in health & immunity related parameters of Dabur Ratnaprash formulatio
- Registration Number
- CTRI/2014/07/004804
- Lead Sponsor
- Dabur India Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
•Male and female subjects aged 18 to 60 years (both the ages inclusive)
•Ready to provide written informed consent
•No history of any known allergy with Chyawanprash like products or any of the ingredientts of the Ratnaprash
•Willing to come for the follow up visits for evaluation
•Presence of clinically significant abnormal laboratory, ECG or X-ray findings during screening.
•Patients with known uncontrolled diabetes mellitus (DM), hypertension (HT), symptomatic congestive heart failure (CHF), unstable angina pectoris, myocardial infarction (MI)
•Patients participated in another clinical drug trial within 3 months before recruitment in this trial
•Any other medical condition that in the Investigators opinion would preclude patient participation
•Pregnant and breast feeding women and women of child bearing age refusing to use contraceptive measures
•Immunologically compromised individuals
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method